|
|
|
Grey Horse Capital Corporation (TSX: GHC)("Grey Horse" or "the Corporation"), a Canadian financial services firm providing transfer agency and corporate trust services to issuers in the North American capital markets, is pleased to announce that it has acquired 100% of the issued and outstanding shares of Global Corporate Compliance Inc. ("Global"). Global is based in Calgary, Alberta and has been privately owned and operated since 1996. Global will operate as a wholly owned subsidiary of Grey Horse and will continue to provide outsourced corporate secretary and regulatory compliance services to its client base of approximately 170 publicly traded issuers across Canada. Grey Horse President and CEO Kevin Reed said, "We are very pleased with this transaction and with Joan's decision to join our team. Global has a service offering and client base that complements our existing operations and will facilitate our entry into the Alberta public issuer market. Global founder and President Joan Moody added, "I'm pleased to be joining the Grey Horse team and look forward to contributing to its growth in Alberta." About Grey Horse Through its wholly owned subsidiary, Equity Transfer & Trust Company, Grey Horse provides transfer agency and corporate trust services to issuers in the North American capital markets. Learn more at www.greyhorsecapital.com. About Global Global provides public issuer services related to shareholders meetings, SEDAR, EDGAR and SEDI filings, whistleblower programs, and other disclosure, administrative and related services. Learn more at www.globalcci.com Certain information included in this press release is forward-looking and may involve risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Factors that might cause a difference include, but are not limited to, competitive developments, risks associated with Grey Horse's growth, the state of the financial markets, regulatory risks and other factors. Unless otherwise required by applicable securities laws, Grey Horse disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. More detailed information about potential factors that could affect Grey Horse's financial and business results is included in public documents Grey Horse files from time to time with Canadian securities regulatory authorities. |
The tests screen for disorders ranging from Tay-Sachs to cystic fibrosis to sickle cell disease, said Dr. Steven J. Ory of IVF Florida Reproductive Associates and former president of the American Society of Reproductive Medicine
Florida's largest fertility clinic announced it is the first in the state to offer the latest weapon in the war against birth defects: a coupling of technologies that will allow couples to avoid passing along more than 100 genetic diseases to their newborn.
The salvo combines a brand-new saliva test - administered before pregnancy - to identify couples at risk of bearing children with genetic diseases, along with an ultra high-tech biopsy process - conducted after conception - to ensure healthy babies.
The tests screen for disorders ranging from Tay-Sachs to cystic fibrosis to sickle cell disease, said Dr. Steven J. Ory of IVF Florida Reproductive Associates and former president of the American Society of Reproductive Medicine. The process lets parents screen for genetic diseases before pregnancy--rather than facing unwelcome news later in pregnancy when tests such as amniocentesis and chorionic villus sampling are done.
"After 30 years in reproductive medicine, I am more optimistic about this development in genetic disease prevention than I've ever been," Ory said. "It appears to be very promising helping parents-to-be routinely screen for many inherited diseases."
The Universal Genetic Test became available in late 2009 from Counsyl, Inc. and can be ordered through IVF Florida with results returned in two weeks. If both parents tests show they are carriers of certain recessive genes, they can undergo IVF, an embryo biopsy and microarray pre-implantation genetic diagnosis (PGD).
"More than 80 percent of children with inherited diseases are born to healthy parents with no family history of those diseases," Ory said. "A five-minute saliva test that helps them avoid such anguish is a major step in disease prevention."
About IVF Florida Reproductive Associates
With seven reproductive specialists in Wellington, Margate, Pembroke Pines and Jupiter/Palm Beach Gardens, IVF Florida is the state's largest reproductive medicine practice and is a member of the IntegraMed Fertility network. One of every five IVF procedures in the U.S. is performed in an IntegraMed practice.
About Counsyl
The Universal Genetic Test was developed by Counsyl, a Stanford startup founded by social entrepreneurs and philanthropists. Counsyl's mission is to end the needless suffering of preventable genetic disease.
IVF Florida Reproductive Associates
CONTACT: Rob Doll, Area Development Director of IVF Florida ReproductiveAssociates, +1-954-247-6219
Web site: http://www.ivfflorida.com/http://www.counsyl.com/






